Quest Diagnostics Inc. income statement & cash flow
In the fiscal year ended Dec 31, 2025, Quest Diagnostics Inc. reported net income of $992.00M on revenue of $11.04B. Operating cash flow was $1.89B and capital expenditures were $527.00M, leaving $1.36B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.21B | $7.40B | $7.53B | $7.73B | $9.44B | $10.79B | $9.88B | $9.25B | $9.87B | $11.04B |
| Gross profit | $2.90B | $2.68B | $2.60B | $2.69B | $3.63B | — | — | — | — | — |
| Operating income | $1.28B | $1.17B | $1.10B | $1.23B | $1.97B | $2.38B | $1.43B | $1.26B | $1.35B | $1.56B |
| Net income | $645.00M | $772.00M | $736.00M | $858.00M | $1.43B | $2.00B | $946.00M | $854.00M | $871.00M | $992.00M |
| Diluted EPS | $4.51 | $5.50 | $5.29 | $6.28 | $10.47 | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
| Operating cash flow | $1.12B | $1.18B | $1.20B | $1.24B | $2.00B | $2.23B | $1.72B | $1.27B | $1.33B | $1.89B |
| Capital expenditures | $293.00M | $252.00M | $383.00M | $400.00M | $418.00M | $403.00M | $404.00M | $408.00M | $425.00M | $527.00M |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | — | 14.1% | 9.0% |
| Dec 2024 | — | 13.6% | 8.8% |
| Dec 2023 | — | 13.6% | 9.2% |
| Dec 2022 | — | 14.4% | 9.6% |
| Dec 2021 | — | 22.1% | 18.5% |
Source: SEC EDGAR XBRL company facts for CIK 1022079 (raw data). Most recent filing in this dataset: 10-Q filed Oct 23, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.